Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis

Thrombosis Research(2021)10.1016/j.thromres.2021.04.019Source: DataRank Database

Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis is a research paper published in Thrombosis Research (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.37)OA: closedTopics (26)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Taylor M. Trussell ORCID,Addison Yee,Mathew P. Malone,Amanda Marshall

Live enrichment

PubMed:33992874 OpenAlex:https://openalex.org/W3157395298

Associazione di Fondazioni e di Casse di Risparmio

Grant: UL1 RR029884

National Center for Advancing Translational Sciences

National Institutes of Health

University of Arkansas for Medical Sciences

FWCI

0.37

Citation Percentile

0.6%

Citation Trend

2024

2025

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0049384821003121?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0049384821003121?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.thromres.2021.04.019

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33992874

Fields of Study

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsHeparin-Induced Thrombocytopenia and ThrombosisAnticoagulantsChildCritical IllnessDrug Administration ScheduleEnoxaparinHumansVenous Thromboembolism

MeSH Terms

AnticoagulantsChildDrug Administration ScheduleHumansCritical IllnessEnoxaparinVenous Thromboembolism

Keywords

MedicineCritically illIntensive care medicineAnticoagulantsBlood coagulationhemorrhageEnoxaparinCoagulation Factor XaDeep Venothromboembolism Prophylaxis

Sustainable Development Goals

SDG 0: Good health and well-being

Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics